For Pree, diagnosed with multiple sclerosis at 19, finishing college was a challenge. Still, amidst it all, she decided to open up about her journey by sharing her first video on YouTube. Little did ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

Treatment with CNM-Au8 led to clinical improvements in relapsing-remitting MS patients that linked to signs of nerve cell ...

A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...